Lung Cancer

Proton Pump Inhibitor and Antibiotic Use May Reduce the Benefit of Immunotherapy in NSCLC

Baseline use of proton pump inhibitors (PPIs) and, to a lesser extent, antibiotics was associated with poorer outcomes in patients…

1 week ago

ACEIs Linked to Lung Cancer

A population based cohort study in the UK showed that the use of angiotensin converting enzyme inhibitors (ACEIs) was associated…

8 years ago

This website uses cookies.